Clinical Trials Directory

Trials / Completed

CompletedNCT07015645

Long-Term Outcomes of Hypopituitarism Following Gamma Knife Radiosurgery for Pituitary Adenomas

Status
Completed
Phase
Study type
Observational
Enrollment
137 (actual)
Sponsor
Al-Azhar University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study aims to assess long-term outcomes of hypopituitarism following gamma knife radiosurgery (GKRS) for pituitary adenomas.

Detailed description

Pituitary adenomas (PAs) are one of the most common intracranial neoplasms, accounting for 10-20% of diagnosed brain tumors. Initial gamma knife radiosurgery (GKRS) can be an alternative treatment for selected NFPA patients with comorbidities, documented growth small tumors, cavernous sinus invasion, or advanced age. Hypopituitarism is one of the most common complications of radiosurgery (Cordeiro et al., 2018). Long-term follow-up is crucial to assess new pituitary deficits. Typically, hypopituitarism presents within the first 2-4 years after the treatment with radiosurgery, but the risk of pituitary insufficiency increases to up to 80%. Reports on the highest incidence of new-onset hypopituitarism also mentioned the longest follow-up period.

Conditions

Interventions

TypeNameDescription
PROCEDUREGamma Knife RadiosurgeryPatients received gamma knife radiosurgery (GKRS) treatment for pituitary adenomas.

Timeline

Start date
2019-01-01
Primary completion
2025-01-01
Completion
2025-01-01
First posted
2025-06-11
Last updated
2025-06-11

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07015645. Inclusion in this directory is not an endorsement.